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CYTOCHROME P450S AND USES THEREOF

tutive. Hoshino et al. (Phytochemistry 38:609-613, 1995)

RELATED APPLICATIONS

try 28:775-779, 1989) by directly measuring 3-hydroxylase

added to the observations of Whitehead et al. (Phytochemis

activity in microsomal preparations of arachidonic acid-elic
This application claims the bene?t of the priority date of
US. patent application Ser. No. 10/097,559 ?led on Mar. 8,
2002 (now issued US. Pat. No. 7,405,057), which claims the
bene?t of US. Provisional Application Nos. 60/274,421 and
60/275,597, ?led on Mar. 9, 2001 and Mar. 13, 2001, respec
tively, all of which are hereby incorporated by reference.

ited Capsicum annuum fruits and seedlings. These assays

consisted of incubating 5-epi-aristolochene with microsome
preparations and subsequently determining the amount of
1-deoxycapsidiol generated by a combination of thin-layer

chromatography (TLC) separations and gas chromatography
(GC). Their evidence demonstrated that the conversion of
5-epi-aristolochene to 1-deoxycapsidiol was dependent on
both NADPH and OZ, and that 1-deoxycapsidiol accumula
tion in vitro was arrested by the P450 antagonists carbon
monoxide (Omura and Sato, J. Biol. Chem. 239:2370-2378,

FIELD OF THE INVENTION

This invention relates to cytochrome P450s and uses
thereof.

1964), ancymidol (Coolbaugh et al., Plant Physiol. 62:571

BACKGROUND OF THE INVENTION

Cytochrome P450s encompass a superfamily of oxidases
responsible for the oxidation of numerous endobiotics and

20

thousands of xenobiotics. In addition, in plants, cytochrome
P450s play important roles in wound healing, pest resistance,
signaling, and anti-microbial and anti-fungal activity.
Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro
duced by many Solanaceous species in response to a variety
of environmental stimuli, including exposure to UV (Back et

jasmonate as an inducer of capsidiol biosynthesis in tobacco

25

cell cultures, Mandujano-ChaveZ et al. (Arch. Biochem. Bio
phys. 381 :285-294, 2000), reported that the modest accumu
lation of this phytoalexin was accompanied by a strong induc
tion of EAS. This result implied that steps before or after the

al., Plant Cell. Physiol. 389:899-904, 1998) and infection by
microorganisms (Molot et al., Physiol. Plant Pathol. 379-389,
1981; Stolle et al., Phytopathology 78:1193-1197, 1988;
Keller et al., Planta. 205:467-476, 1998). It is the primary

576, 1978), and ketoconazole (Rademacher, Annu. Rev. Plant
Physiol. Plant Mol. Biol. 51:501-531, 2000).
Recent results suggest that the hydroxylation of 5-epi
aristolochene is an important regulated step in capsidiol bio
synthesis. In studies to evaluate the effectiveness of methyl

sesquiterpene cyclase reaction were limiting. Using an in vivo
assay measuring the conversion rate of radiolabeled 5-epi
30

aristolochene to capsidiol, a very limited induction of the
hydroxylase activities was observed in cells treated with

antibiotic or phytoalexin produced in tobacco in response to

methyl jasmonate relative to that in fungal elicitor-treated

fungal elicitation, and it is derived from the isoprenoid path
way via its hydrocarbon precursor, 5-epi-aristolochene (FIG.
1). Several of the biosynthetic enzymes leading up to 5-epi

potentially limiting step in capsidiol biosynthesis.

aristolochene formation have been studied (Chappell, Annu.
Rev. Plant Physiol. Plant Mol. Biol. 46:521-547, 1995), espe

cells. This result pointed to the hydroxylase reactions as a

35

cially 5-epi-aristolochene synthase (BAS) (Vogeli and Chap

In one aspect, the invention features several isolated cyto

pell, Plant Physiol. 88: 1291 -1296, 1988; Back and Chappell,

chrome P450 polypeptides (such as CYP71D20, CYP71D21,
CYP73A27, CYP73A28, and CYP92A5, and P450s having

Proc. Natl. Acad. Sci. U.S.A. 93:6841-6845, 1996; Mathis et

al., Biochemistry 36:8340-8348, 1997; Starks et al., Science
277: 1815-1820, 1997). BAS commits carbon to sesquiter

40

pene metabolism by catalyZing the cyclization of famesyl
diphosphate (FPP) to 5-epi-aristolochene. However, until the
present invention, the Biochemical evidence from previous
studies in tobacco (Whitehead et al., Phytochemistry 28:775
779, 1989) and green pepper (Hoshino et al., Phytochemistry
38:609-613, 1995) have suggested that the oxidation of 5-epi

45

substantial identity to these polypeptides), as well as isolated
nucleic acid molecules that encode these P450s.
In related aspects, the invention features a vector (such as
an expression vector) including an isolated nucleic acid mol
ecule of the invention and a cell (for example, a prokaryotic
cell, such as Agrobaclerium or E. coli, or a eukaryotic cell,

such as a mammalian, insect, yeast, or plant cell) including
the isolated nucleic acid molecule or vector.

aristolochene to capsidiol occurs in a two step process with

one of the hydroxylation steps being constitutive and the
other being mediated by an elicitor-inducible cytochrome

SUMMARY OF THE INVENTION

50

P450 (FIG. 1). Because 1-deoxycapsidiol had been isolated

In yet another aspect, the invention features a transgenic
plant or transgenic plant component including a nucleic acid
molecule of the invention, wherein the nucleic acid molecule
is expressed in the transgenic plant or the transgenic plant

from natural sources (Watson et al., Biochem. Soc. Trans.

component. Preferably, the transgenic plant or transgenic

11:589, 1983), Whitehead et al. (Phytochemistry 28:775-779,
1989), surmised that perhaps the biosynthesis of this inter

plant component is an angiosperm (for example, a monocot or

mediate was due to pathogen induction of a corresponding

55

dicot). In preferred embodiments, the transgenic plant or
transgenic plant component is a solanaceous, maize, rice, or

hydroxylase. They therefore prepared synthetic 1-deoxycap

cruciferous plant or a component thereof. The invention fur

sidiol and reported a modest conversion of this compound to
capsidiol when fed to control or unelicited tobacco cell cul
tures. This was further supported by their observation that
radiolabeled 5-epi-aristolochene was only converted to cap

ther includes a seed produced by the transgenic plant or
transgenic plant component, or progeny thereof.
60

In another aspect, the invention features a method of pro
viding an increased level of resistance against a disease

sidiol when fed to elicitor-induced cell cultures but not con

caused by a plant pathogen in a transgenic plant. The method

trol cultures. Whitehead et al. (Phytochemistry 28:775-779,
1989) therefore concluded that the 3-hydroxylase, respon
sible for hydroxylation of 5-epi-aristolochene at C3 to gen
erate 1-deoxycapsidiol, was pathogen/elicitor inducible,

nucleic acid molecule of the invention integrated into the
genome of the transgenic plant cell and positioned for expres

involves: (a) producing a transgenic plant cell including the
65

sion in the plant cell; and (b) growing a transgenic plant from

while the 1-hydroxylase, responsible for hydroxylating

the plant cell wherein the nucleic acid molecule is expressed

1-deoxycapsidiol at the C1 to generate capsidiol, was consti

in the transgenic plant and the transgenic plant is thereby

US 8,263,362 B2
3

4

provided with an increased level of resistance against a dis
ease caused by a plant pathogen.
In another aspect, the invention features a method for pro

of comparison sequences will generally be at least 50 nucle
otides, preferably at least 60 nucleotides, more preferably at
least 75 nucleotides, and most preferably 110 nucleotides.

ducing an altered compound, the method including the steps

Sequence identity is typically measured using sequence
analysis software (for example, Sequence Analysis Software

of contacting the compound with one or more of the isolated

Package of the Genetics Computer Group, University of Wis
consin Biotechnology Center, 1710 University Avenue,

polypeptides disclosed herein under conditions allowing for
the hydroxylation, oxidation, demethylation, or methylation
of the compound and recovering the altered compound.

Madison, Wis. 53705, BLAST, or PILEUP/PRETTYBOX

In still another aspect, the invention features a hydroxylat

programs). Such software matches identical or similar

ing agent including any of the isolated polypeptides disclosed

sequences by assigning degrees of homology to various sub
stitutions, deletions, and/or other modi?cations. Conserva

herein.
In yet another embodiment, the invention features an iso

tive substitutions typically include substitutions within the

lated nucleic acid molecule that speci?cally hybridizes under
highly stringent conditions to the complement of any one of
the sequences described in SEQ ID NO:2 (CYP71D20), SEQ
ID NO:4 (CYP71D21), SEQ ID N016 (CYP73A27), SEQ ID
N018 (CYP73A28), or SEQ ID NO: 12 (CYP92A5), wherein

following groups: glycine alanine; valine, isoleucine, leu

cine; aspartic acid, glutamic acid, asparagine, glutamine;
serine, threonine; lysine, arginine; and phenylalanine,
tyrosine.
By an “isolated polypeptide” is meant a P450 polypeptide

such a nucleic acid molecule encodes a cytochrome P450

polypeptide.
In another aspect, the invention features a host cell express

20

ing a recombinant isoprenoid synthase and a recombinant

cytochrome P450. In preferred embodiments, the host cell
further expresses, independently or in combination, a recom

binant acetyltransferase, methyltransferase, or fatty acyl
transferase. In other preferred embodiments, the host

25

expresses an endogenous or recombinant cytochrome reduc
tase. Preferably, the host cell is a yeast cell, a bacterial cell, an
insect cell, or a plant cell.
In a related aspect, the invention features a method for

producing an isoprenoid compound, the method including the

30

(for example, a CYP71D20 (SEQ ID NO: 1), CYP71D21
(SEQ ID NO:3), CYP73A27 (SEQ ID NO:5), CYP73A28
(SEQ ID NO:7), or CYP92A5 (SEQ ID NO:1 1) polypeptide)
that has been separated from components that naturally
accompany it. Typically, the polypeptide is isolated when it is
at least 60%, by weight, free from the proteins and naturally
occurring organic molecules with which it is naturally asso
ciated. Preferably, the preparation is at least 75%, more pref
erably at least 90%, and most preferably at least 99%, by
weight, a P450 polypeptide. An isolated P450 polypeptide
may be obtained, for example, by extraction from a natural
source (for example, a plant cell); by expression of a recom
binant nucleic acid encoding a P450 polypeptide; or by

steps of: (a) culturing a cell that expresses a recombinant

chemically synthesizing the protein. Purity can be measured

isoprenoid synthase and a recombinant cytochrome P450
under conditions wherein the isoprenoid synthase and the
cytochrome P450 are expressed and catalyze the formation of
an isoprenoid compound not normally produced by the cell;

by any appropriate method, for example, column chromatog
raphy, polyacrylamide gel electrophoresis, or by HPLC

analysis.
35

and (b) recovering the isoprenoid compound. In preferred

sequence (e.g., cDNA, genomic DNA, synthetic, or combi
nation thereof).

embodiments, the host cell further expresses a recombinant
acetyltransferase, a recombinant methyltransferase, or a

recombinant fatty acyltransferase. In other preferred embodi
ments, the host cell expresses an endogenous or recombinant

By “derived from” or “obtained from” is meant isolated
from or having the sequence of a naturally-occurring

40

By “isolated nucleic acid molecule” is meant a nucleic acid
molecule, e.g., a DNA molecule, that is free of the nucleic

cytochrome reductase. Preferably, the host cell is a yeast cell,

acid sequence(s) which, in the naturally-occurring genome of

a bacterial cell, an insect cell, or a plant cell.

By “P450 polypeptide,” “cytochrome P450,” or “P450” is

the organism from which the nucleic acid molecule of the
invention is derived, ?ank the nucleic acid molecule. The
term therefore includes, for example, a recombinant DNA
that is incorporated into a vector; into an autonomously rep
licating plasmid or virus; or into the genomic DNA of a

meant a polypeptide that contains a heme-binding domain
and shows a CO absorption spectra peak at 450 nm according

prokaryote or eukaryote; or that exists as a separate molecule
(for example, a cDNA or a genomic or cDNA fragment pro

In yet another aspect, the invention features an isoprenoid

compound produced according to the above-mentioned
methods.
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lase activity, dual hydroxylase activity, demethylase activity,

duced by PCR or restriction endonuclease digestion) inde
pendent of other sequences. The term “isolated nucleic acid
molecule” also includes a recombinant DNA which is part of

or oxidase activity. Such enzymatic activities are determined
using methods well known in the art.

a hybrid gene encoding additional polypeptide sequence.
By “speci?cally hybridizes” is meant that a nucleic acid

to standard methods, for example, those described herein.
Such P450s may also include, without limitation, hydroxy

50

By “polypeptide” is meant any chain of amino acids,

regardless of length or post-translational modi?cation (for
example, glycosylation or phosphorylation).

sequence is capable of hybridizing to a DNA sequence at least
55

By “substantially identical” is meant a polypeptide or

nucleic acid exhibiting at least 800r 85%, preferably 90%,
more preferably 95%, and most preferably 97%, or even 98%

identity to a reference amino acid sequence (for example, the
amino acid sequence shown in SEQ ID NOS: 1, 3, 5, 7, and 1 1)
or nucleic acid sequence (for example, the nucleic acid

60

tions may include hybridization at approximately 42° C. in
about 50% formamide, 0.1 mg/ml sheared salmon sperm
DNA, 1% SDS, 2><SSC, 10% Dextran sulfate, a ?rst wash at
approximately 65° C. in about 2><SSC, 1% SDS, followed by
a second wash at approximately 650 C. in about 0.1><SSC.

Alternatively high stringency conditions may include hybrid
ization at approximately 420 C. in about 50% formamide, 0.1

sequences shown in SEQ ID NOS:2, 4, 6, 8, and 12, respec
tively). For polypeptides, the length of comparison sequences
will generally be at least 16 amino acids, preferably at least 20
amino acids, more preferably at least 25 amino acids, and
most preferably 35 amino acids. For nucleic acids, the length

under low stringency conditions, and preferably under high
stringency conditions. For example, high stringency condi

mg/ml sheared salmon sperm DNA, 0.5% SDS, 5><SSPE,
65

1><Denhardt’s, followed by two washes at room temperature
in 2><SSC, 0.1% SDS, and two washes at between 55-600 C.

in 0.2><SSC, 0.1% SDS. Reducing the stringency of the

US 8,263,362 B2
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hybridization conditions may involve lowering the wash tem

diseases caused by these pathogens are described in Chapters
11-16 of Agrios, Plant Pathology, 3rd ed., Academic Press,
Inc., New York, 1988.

perature and/ or washing at a higher concentration of salt. For

example, low stringency conditions may include washing in
2><SSC, 0.1% SDS at 40° C.
By “transformed cell” is meant a cell into which (or into an
ancestor of which) has been introduced, by means of recom

By “increased level of resistance” is meant a greater level
of resistance to a disease-causing pathogen in a transgenic
plant (or cell or seed thereof) of the invention than the level of
resistance relative to a control plant (for example, a non

binant DNA techniques, a DNA molecule encoding (as used
herein) a P450 polypeptide.
By “positioned for expression” is meant that the DNA

transgenic plant). In preferred embodiments, the level of

molecule is positioned adjacent to a DNA sequence which

resistance in a transgenic plant of the invention is at least 20%
(and preferably 30% or 40%) greater than the resistance of a

directs transcription and translation of the sequence (i.e.,
facilitates the production of, for example, a P450 polypeptide,

resistance to a disease-causing pathogen is 50% greater, 60%

a recombinant protein, or an RNA molecule).

greater, and more preferably even 75% or 90% greater man a

control plant. In other preferred embodiments, the level of

By “reporter gene” is meant a gene whose expression may

control plant; with up to 100% above the level of resistance as

be assayed; such genes include, without limitation, beta-glu

compared to a control plant being most preferred. The level of
resistance is measured using conventional methods. For
example, the level of resistance to a pathogen may be deter

curonidase (GUS), luciferase, chloramphenicol transacety
lase (CAT), green ?uorescent protein (GFP), beta-galactosi
dase, herbicide resistant genes, and antibiotic resistance
genes.

By “expression control region” is meant any minimal

20

sequence suf?cient to direct transcription. Included in the
invention are promoter elements that are suf?cient to render

mined by comparing physical features and characteristics (for
example, plant height and weight, or by comparing disease
symptoms, for example, delayed lesion development,
reduced lesion size, leaf wilting and curling, water-soaked
spots, and discoloration of cells) of transgenic plants.

promoter-dependent gene expression controllable for cell-,

By “puri?ed antibody” is meant antibody which is at least

tissue-, or organ-speci?c gene expression, or elements that

60%, by weight, free from proteins and naturally-occurring

are inducible by external signals or agents (for example,
light-, pathogen-, wound-, stress-, or hormone-inducible ele

25

ments or chemical inducers such as salicylic acid (SA) or

2,2-dichloro isonicotinic acid (INA)); such elements may be
located in the 5' or 3' regions of the native gene or engineered
into a transgene construct.

30

organic molecules with which it is naturally associated. Pref
erably, the preparation is at least 75%, more preferably 90%,
and most preferably at least 99%, by weight, antibody, for
example, an acquired resistance polypeptide-speci?c anti
body. A puri?ed P450 antibody may be obtained, for

example, by af?nity chromatography using a recombinantly

By “operably linked” is meant that a gene and a regulatory
sequence(s) are connected in such a way as to permit gene

produced P450 polypeptide and standard techniques.

expression when the appropriate molecules (for example,

nizes and binds a P450 protein but which does not substan

By “speci?cally binds” is meant an antibody which recog

transcriptional activator proteins) are bound to the regulatory

sequence(s).
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By “plant cell” is meant any self-propagating cell bounded
by a semi-permeable membrane and typically is one contain
ing a plastid. Such a cell also requires a cell wall if further
propagation is desired. Plant cell, as used herein includes,

without limitation, algae, cyanobacteria, seeds, suspension
cultures, embryos, meristematic regions, callus tissue, leaves,
roots, shoots, gametophytes, sporophytes, pollen, and

tially recognize and bind other molecules in a sample, for
example, a biological sample, which naturally includes a
P450 protein such as CYP71D20, CYP71D21, CYP73A27,
CYP73A28, or CYP92A5.

Other features and advantages of the invention will be

apparent from the following description of the preferred
40

embodiments thereof, and from the claims.
BRIEF DESCRIPTION OF THE DRAWINGS

microspores.
By “plant component” is meant a part, segment, or organ
obtained from an intact plant or plant cell. Exemplary plant

FIG. 1 is a schematic diagram of a proposed alternative
45

components include, without limitation, somatic embryos,
leaves, stems, roots, ?owers, tendrils, fruits, scions, and root

pathway for the biosynthesis of capsidiol in elicitor-treated
Nicoliana labacum cells. 5-epi-aristolochene is synthesized
from FPP by the action of a sequiterpene cyclase, 5-epi

stocks.

aristolochene synthase (EAS), and is subsequently hydroxy

By “transgene” is meant any piece of DNA which is
inserted by arti?ce into a cell and typically becomes part of
the genome, for example, the nuclear or plastidic genome, of
the organism which develops from that cell. Such a transgene
may include a gene which is partly or entirely heterologous
(i.e., foreign) to the transgenic organism, or may represent a
gene homologous to an endogenous gene of the organism.

lated at C1 and C3 to form capsidiol.
FIG. 2 is a graph showing an induction time course for

50

sesquiterpene cyclase enzyme activity and sesquiterpene
hydroxylase activity in cellulase-treated cell cultures. Ses

quiterpene cyclase (5-epi-aristolochene synthase, EAS)
enzyme activity was determined in extracts prepared from
55

part of the genome of the organism which develops from that
cell. As used herein, the transgenic organisms are generally

transgenic plants and the DNA (transgene) is inserted by

control (open squares) and elicitor-treated (closed squares)
cells collected at the indicated time points. Sesquiterpene
hydroxylase activity was determined using an indirect assay

By “transgenic” is meant any cell which includes a DNA
sequence which is inserted by arti?ce into a cell and becomes

for control (open circles) and elicitor-treated (closed circles)
60

cells. Cell cultures were incubated with [3H]-5-epi-aris
tolochene for 3 hours ending at the indicated time points

arti?ce into the nuclear or plastidic genome. A transgenic

before quantifying the incorporation of radioactivity into

plant according to the invention may contain one or more

extracellular capsidiol, a dihydroxylated form of aris
tolochene (Mandujano-Chavez et al., Arch. Biochem. Bio

engineered traits.
By “pathogen” is meant an organism whose infection of
viable plant tissue elicits a disease response in the plant tissue.

Such pathogens include, without limitation, bacteria, myco
plasmas, fungi, insects, nematodes, viruses, and viroids. Plant

phys. 381:285-294, 2000).
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FIG. 3 is a series of graphs showing the dose dependent

inhibition of 5-epi-aristolochene hydroxylase activity by
ancymidol and ketoconazole. Cell cultures were incubated in

US 8,263,362 B2
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the presence of cellulase (0.5 ug/mL) plus the indicated con
centrations of ancymidol (A) or ketoconazole (B) for 12 hours

encodes for kaurene oxidase, which catalyzes a 3-step reac
tion including a hydroxylation followed by oxidation of a

prior to measuring the in vivo 5-epi-aristolochene hydroxy

diterpene (Helliwell et al., Plant Physiol. 119:507-510,

lase activity in the cell suspension cultures (squares), or the
EAS enzyme activity in extracts prepared from the collected
cells (triangles). The in vitro activity of a puri?ed EAS prepa
ration (Back and Chappell, J. Biol. Chem. 270:7375-7381,

1999). Shown are sequences from Menlha piperila

1995) was also measured at the indicated inhibitor concen
trations as an additional test for non-speci?c effects of these

(MpCYP71D13; SEQ ID NO139), Menlha spicala
(MsCYP71D18; SEQ ID NO:40), Nepela racemosa
(NrCYP71A5v1; SEQ ID NO:41), Nicoliana Zabacum
(NtCYP71D20; SEQ ID NO:1), Persea americana
(PaCYP71A1; SEQ ID NO:42), and Arabidopsis Zhaliana

inhibitors (circles).

(CYP701A3; SEQ ID NO:43). Conserved residues are

FIG. 4A is a schematic diagram of the primary structure of
a generalized cytochrome P450 with conserved domains used

shaded.

for the design of PCR primers highlighted (SEQ ID NOS:26

DETAILED DESCRIPTION

29).
Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro

FIG. 4B is a list of the degenerate P450-speci?c primers
(SEQ ID NOS:30-36) that were used in various combinations

duced by several Solanaceous species in response to a variety
of environmental stimuli. It is the primary antimicrobial com

with vector speci?c primers in the ampli?cation of cyto
chrome P450 cDNA fragments.
FIG. 4C is a scanned image of an ethidium bromide-stained

agarose gel showing the PCR products ampli?ed from a
directional cDNA library prepared with mRNA isolated from
elicitor-treated cells using the degenerate primer GRRXCP

(A/G)ifor (SEQ ID NO:35) and the T7 vector-speci?c
primer (SEQ ID NO:37). The T3 vector-speci?c primer is
also shown (SEQ ID NO:38).

20

capsidiol.
25

FIG. 5 is a series of Northern blots showing the induction

ketoconazole, two well-characterized inhibitors of cyto

chrome P450 enzymes. Using degenerate oligonucleotide
30

fractionated by agarose gel electrophoresis under denaturing

35

yeast expressing the CYP92A5 (A) and CYP71D20 (B)
cDNAs. Expression of the respective plasmid constructs

10), and CYP92A5 (SEQ ID NO: 12)), and these in turn were
40

galactose treatment, followed by isolation of microsomal
preparations. The difference adsorption spectra of
microsomes incubated in the presence (solid lines) and
absence (broken lines) of carbon monoxide was determined.
FIG. 7 is a series of gas chromatograms of the reaction
products formed upon incubation of microsomes isolated
from WAT11 yeast cells containing the CYP71D20 expres
sion construct (A and C) or vector control DNA (B and D)
with sesquiterpene substrates. Microsomes isolated from the
indicated yeast lines were incubated with 5-epi-aristolochene

45

Using an indirect assay, a detailed induction time course of
50

5EAH activity in elicitor-induced cell cultures was deter

mined relative to that of EAS activity (FIG. 2), the well

characterized sesquiterpene cyclase activity that catalyzes the
formation of 5-epi-aristolochene from FPP (FIG. 1). Using
55

assays for EAS and 5EAH, EAS activity is not detectable in
control cell cultures, but is induced signi?cantly within 3
hours and reaches its maximal level within 15 to 18 hours of
elicitor-treatment. Similar to the EAS enzyme activity, 5EAH

(sesquiterpene) hydroxylase NtCYP71D20 (SEQ ID NO:1)
with other plant terpene hydroxylases (SEQ ID NOS:39-43).

mono-hydroxylation at C6 and C3 of limonene, a cyclic

There now follows a description of the cloning of several
P450s from Nicoliana Zabacum. These examples are provided
for the purpose of illustrating the invention, and are not to be
considered as limiting.
Inhibition of the 5-epi-aristolochene to Capsidiol Conversion

by P450 Antagonists

were veri?ed by mass spectrometry.

NrCYP71A5v1 (GenBank accession number CAA70575)
catalyzes the mono-hydroxylation of nerol and geraniol, lin
ear monoterpenes, while PaCYP71A1 (A35867) catalyzes
the epoxidation of these substrates (Hallahan et al., Biochim.
Biophys. Acta. 1201 :94-100, 1994). MsCYP71D18
(AAD44150) and MpCYP7 1 D13 (AAD44151) catalyze the

used to demonstrate that the corresponding mRNAs were all

induced in elicitor-treated cells, albeit with different induc
tion patterns.

(A and B) or 1-deoxycapsidiol (C and D) in the presence
(solid lines) or absence (dashed lines) of NADPH. The iden
tities of 5-epi-aristolochene, 1-deoxycapsidiol, and capsidiol
FIGS. 8A-8D provide a sequence comparison of the amino
acid sequence of Nicoliana labacum 5-epi-aristolochene

?ed from a cDNA library prepared against mRNA from elici
tor-treated cells using PCR. The PCR fragments were subse

quently used to isolate full-length cDNAs (CYP71D20 (SEQ
ID NO: 2) and D21 (SEQ ID NO: 4), CYP73A27 (SEQ ID
NO: 6) and A28 (SEQ ID NO: 8), CYP82E1 (SEQ ID NO:

FIG. 6 is a series of graphs showing carbon monoxide (CO)
difference spectra of the microsomal fraction isolated from
engineered into the yeast (WAT11) cells was induced by a

primers designed to the well-conserved domains found
within most P450 enzymes, including the heme binding

domain, cDNA fragments representing four distinct P450
families (CYP71, CYP73, CYP82, and CYP92) were ampli

conditions, and transferred to a nylon membrane before prob

ing with the respective full-length cDNAs. The uniformity of
sample loading was veri?ed by ethidium bromide staining of
ribosomal RNA (Loading control).

Accordingly, an in vivo assay for 5-epi-aristolochene
hydroxylase-activity was developed and used to demonstrate

a dose dependent inhibition of activity by ancymidol and

time course for CYP71D, CYP73A, CYP82E, CYP92A, and
EAS transcript accumulation in elicitor treated cells. Total
RNA was extracted from tobacco suspension cells incubated
with the cellulase elicitor for the indicated durations, size

pound produced by Nicoliana labacum in response to fungal
elicitation, and it is formed via the isoprenoid pathway from
5-epi-aristolochene. Much of the biosynthetic pathway for
the formation of this compound has been elucidated, except
for the enzyme(s) responsible for the conversion of the allylic
sesquiterpene 5-epi-aristolochene to its dihydroxylated form,
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activity was negligible in control cell cultures. Nonetheless,
after an apparent lag phase of 8 hours, a rapid induction of
hydroxylase activity was observed 10 to 15 hours post elicitor
addition to the cell cultures, reaching a maximum by 18 hours
followed by a rather gradual decline of 10 to 20% over the
next 8 hours.
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Tobacco cell suspension cultures treated with cellulase
plus varying concentrations of ancymidol or ketoconazole

monoterpene, respectively (Lupien et al., Arch. Biochem.

were pre-incubated for 12 hours before measuring the cells’

Biophys. 368:181-192, 1999). AtCYP701A3 (AAC39505)

ability to convert exogenous supplied [3 H] labeled 5-epi

